![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, May 10, 2017 9:51:29 PM
I'm still a believer that the multiple myeloma study, once moved to orphan drug, will send this stock well into double digits.
I've been through stock declines before, which is why I always take my original investment out and sometimes a little more when I feel near term highs have been put in. Stock swings are tough, but good DD always prevails. Hang in there all, the real data and IP is near and so is the announcement of other uses for the cream.
Long and strong here! And congrats to flippers like Retired Early for making an amazing profit but still realizing the potential and staying long with some of his shares! Always stay in your comfort zone when investing!
GLTA
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM